Dr. Soon-Shiong joins Nobel laureates, former NIH directors, and leading oncology pioneers in Washington, D.C. to chart a path toward defeating cancer by 2035, with the discussion streamed live at ...

O]ur companies have until June of 2028 to get there. That should not be a sigh of relief. That should be a, oh my gosh, we've got a lot of work," said Major.

Vir Biotechnology and Astellas entered a license agreement to co-develop and commercialize Vir's prostate cancer treatment. The agreement is for VIR-5500, a dual-masked T-cell engager targeting ...

A new Research Triangle company, Persistence Therapeutics, is developing a small, implantable device that generates and delivers genetically engineered T cells directly inside the body. These cells, ...

SFDA is supporting safer food systems, more effective health care regulation and a stronger environment for research ...

The compounds have exploded in popularity, but big questions about safety and effectiveness are still unresolved.

The United States has long led the global biomedical research and pharmaceutical development industry - but that leadership ...

The latest wellness craze involves injecting these molecules for athletic performance, longevity and more. Scientists say the ...

The humble breadcrumb could hold the key to cutting out fossil fuels from one of the chemical industry's most widely used ...

The National Security Commission on Emerging Biotechnology is visiting Pittsburgh to talk about how biotechnology and artificial intelligence will play a role in the city.

Carnegie Mellon University and the University of Pittsburgh offered rare looks Thursday into two cutting-edge research facilities during a showcase for the U.S. National Security Commission on ...

Gossamer Bio will be reporting the outcome of a late-stage study in pulmonary arterial hypertension. Here's what to know.